Lassa virus (LASV) small zinc-finger protein (Z), which contains two L-domain motifs, plays a central role in virus budding. Here, we report that co-expression of glycoprotein (GPC) altered the requirements for cholesterol but not the L-domains and host factor, Tsg101, for Z-induced viruslike particle (VLP) production. In particular, the cholesterol requirement for VLP production was cell-type-dependent. In addition, GPC was found to be important for co-localization of Z with CD63, a late endosomal marker. We also found that the N-terminal region (aa 3-10) of Z was critical for its myristoylation and VLP production. These findings will contribute to our understanding of LASV assembly and budding.
INTRODUCTION
Arenaviruses are bisegmented RNA viruses, and both segments encode two viral proteins: the nucleoprotein (NP) and glycoprotein (GPC) are encoded by the S segment, whilst RNA polymerase (L) and small zinc-finger protein (Z) are encoded by the L segment (Buchmeier et al., 2013) . Several arenaviruses cause haemorrhagic fever in humans. Lassa virus (LASV) causes Lassa fever, which has high morbidity and mortality rates. Therefore, LASV is a major health concern in West Africa, where several hundred thousand cases of infection are reported annually.
All arenavirus Z proteins have the same structural properties (Urata & Yasuda, 2012) . The N terminus includes Gly at position 2 (G2). G2 of Z is known to be myristoylated and is critical for cellular membrane attachment and subsequent virion release (Perez et al., 2004; Strecker et al., 2006) . The central domain includes the RING domain (zinc-finger motif), which has been shown to regulate genome replication and gene transcription (Cornu & de la Torre, 2001 , 2002 Cornu et al., 2004; Emonet et al., 2011; Kranzusch & Whelan, 2011; . The C terminus includes L-domains, which are known to regulate the virus budding process. All reported arenavirus Z proteins have been shown to play a central role in virus budding Strecker et al., 2003; Urata et al., 2006 Urata et al., , 2009 . Therefore, Z is considered to be an arenavirus matrix protein. The short amino acid motifs PT/ SAP, PPxY, YPXnL and FPIV have been reported as consensus sequences of the L-domain (Bieniasz, 2006; Chen & Lamb, 2008; Freed, 2002) . PT/SAP and YPXnL interact with Tsg101 and Alix/AIP1, respectively (MartinSerrano et al., 2003; Strack et al., 2003) . These host factors are involved in the endosomal sorting complex required for transportation (ESCRT) machinery. The PPxY motif interacts with E3 ligases of the Nedd4 family, but the role of E3 ligases in virus budding has not been determined (MartinSerrano et al., 2005) . LASV Z possesses two canonical Ldomain motifs, PTAP and PPPY, at its C terminus. Both of these motifs are important for LASV budding Strecker et al., 2003) .
In the present study, we found that GPC, but not NP, influenced the Z-mediated virus-like particle (VLP) production efficiency in a cell-type-dependent manner. We also examined the cholesterol requirement for Z-and Z+GPC-mediated VLP production in several cell lines, and found that the cholesterol requirement for VLP production is also cell-type-dependent. In addition, we showed that GPC expression is important for co-localization of Z with CD63, which is a late endosomal marker. Finally, we examined the involvement of other regions of Z than G2 and L-domains in Lassa VLP production, and found that the region from aa 3 to 10 is important for myristoylation of Z and subsequent VLP production. These findings contribute to our understanding of LASV Zmediated VLP production, especially the trans (GPC and cellular cholesterol) and cis (aa 3-10 in LASV Z) elements that are important for Lassa VLP production.
Z, pCLV-Z, was transfected into 293T cells together with expression plasmids for LASV GPC (pCLV-GPC) and/or for LASV NP (pCLV-NP-HA), and the levels of VLP production were examined as described in Methods. As shown in Fig. 1(a) , co-expression of GPC and NP did not affect the cellular expression of Z. Co-expression of GPC together with Z decreased Z-mediated VLP production (50 %), whilst NP expression did not significantly affect Zmediated VLP production or Z+GPC-mediated VLP production in 293T cells.
Effects of cholesterol depletion on Lassa VLP production
Previously, LASV GPC was reported to redirect Z from the basolateral side to the apical side in the polarized cell line MDCK-II (Schlie et al., 2010b) . Although 293T cells are not known as a polarized cell line, it is possible that the reduction of Z-mediated VLP production by GPC in 293T cells was due to the alteration of processing or the assembly/release site of VLP production in the cell. In particular, we focused on lipid rafts, which are microdomains on the cell surface that consist mainly of cholesterol and lipids (Simons & Sampaio, 2011) . In fact, several viruses have been reported to utilize lipid rafts as a budding platform (Kerviel et al., 2013; Takeda et al., 2003) . In addition, it has been reported that cholesterol presents on the envelope of LASV and is important for virus infectivity (Schlie et al., 2010a) . To examine whether lipid rafts are involved in VLP production, we treated 293T cells with 8.7 mM methyl-b-cyclodextrin (MbCD), which is known to disrupt lipid rafts by chelating cholesterol, for 30 min prior to transfection with pCLV-Z or pCLVZ+pCLV-GPC. MbCD treatment did not affect the intracellular expression of Z or GP2 (Fig. 1b) . MbCD treatment had little effect on Z-mediated VLP production, whilst Z+GPC-mediated VLP production was significantly decreased by MbCD treatment (Fig. 1b) . We next examined whether the effects of MbCD treatment on Z or Z+GPC VLP production were cell-type-dependent. Huh-7 and Vero cells were treated with MbCD or control DMSO, and transfected with pCLV-Z or pCLV-Z+pCLV-GPC, as described in Methods. As GPC/GP2 could not be detected by anti-GPC/GP2 antibody in MDCK cell lysates, pCLV-GPC-FLAG was transfected instead of pCLV-GPC and anti-FLAG antibody was used to detect LASV GP2 in MDCK cells. In Huh-7 cells (Fig. 1c, left panel) , the levels of Z and GPC expression were equivalent between the DMSO and MbCD treatment groups. VLP production induced by Z was reduced upon GPC co-expression, similar to our observations in 293T cells (Fig. 1a, lanes 1  and 2) . In addition, VLP production induced by Z+GPC was reduced upon MbCD treatment in Huh-7 cells, similar to our observations in 293T cells (Fig. 1b) , whilst VLP production induced by Z alone was unaffected by MbCD treatment. In Vero cells (Fig. 1c, middle panel) , although there were modest reductions in Z and GPC expression upon MbCD treatment, both Z-and Z+GPC-induced VLP production were markedly reduced upon MbCD treatment compared with control DMSO treatment. In MDCK cells (Fig. 1c, right panel) , Z and GPC expression levels were equivalent between the DMSO and MbCD 293T cells were transfected with pCLV-Z alone or with a combination of pCLV-GPC and/or pCLV-NP-HA. The empty vector, pCAGGS, was transfected to adjust the total amount of plasmid. At 48 h post-transfection, culture supernatants were collected, and VLPs were collected by ultracentrifugation as described previously (Urata et al., 2006) . Cell lysates were prepared and VLPs were subjected to SDS-PAGE, followed by Western blotting using polyclonal antibodies against LASV Z, LASV GP2, as well as HA to detect LASV NP (left). The intensities of the bands were quantified by LAS3000 (Fujifilm). The efficiencies of VLP production were calculated as VLP-associated Z/ Cell-associated Z. The efficiency of LASV Z alone was set to 1.0 and relative VLP production is shown in the right panel. The data are means±SD from three independent experiments. (b, c) Involvement of cholesterol in Lassa VLP production in different cell lines. 293T cells (b) and Huh-7 and Vero cells (c) were pre-treated with DMSO or MbCD (8.7 mM) for 30 min and washed once with PBS (-), followed by transfection with pCLV-Z and pCAGGS (empty vector) or pCLV-Z and pCLV-GPC. In the case of MDCK cells, pCLV-GPC-FLAG was transfected instead of pCLV-GPC. At 48 h post-transfection, VLPs and cell lysates were analysed as described above.
treatment groups, and MbCD treatment did not affect Zor Z+GPC-mediated VLP production. In all cell lines tested, no or only modest cell toxicity was observed based on Z or GPC/GP2 expression levels in the cells.
Intracellular localization of LASV Z and GPC/GP2
Our data shown in Fig. 1(b) suggested that cholesterol is required for Z+GPC VLP production in 293T cells.
Confocal microscopy was performed to examine whether Z and GPC are co-localized at lipid rafts as a membrane budding platform. 293T cells were transfected with pCLV-Z-FLAG, pCLV-GPC or pCLV-Z-FLAG+pCLV-GPC and fixed at 24 h post-transfection. Z was detected by mouse anti-FLAG mAb and GPC/GP2 was detected by rabbit anti-GPC/GP2 polyclonal antibody. In addition, lipid rafts were detected using a Vybrant Alexa Fluor 555 Lipid Raft labelling kit containing cholera toxin subunit B (CT-B) to bind specifically to the plasma membrane (PM) lipid raft marker, ganglioside GM1. When LASV Z was expressed alone, Z was localized mainly at the PM, but colocalization of Z and rafts was not observed (Fig. 2a) . GPC/GP2 was also localized mainly at the PM, but colocalization of GPC/GP2 and lipid rafts was not detected (Fig. 2b) . Although co-localization of Z and GPC/GP2 was observed at a limited point near the PM when both were expressed ( Fig. 2c, d , arrow), co-localization of lipid rafts and Z/GPC/GP2 was not observed (Fig. 2d, e) . Next, we focused on CD63, which is a late endosomal marker that was shown previously to be co-localized with LASV Z in . LASV Z and GPC/GP2 do not co-localize at lipid rafts. 293T cells were cultured on poly-L-lysine-coated cover slips and transfected with pCLV-Z-FLAG (a), pCLV-GPC (b), or both pCLV-Z-FLAG and pCLV-GPC (c-e). All samples were fixed at 24 h post-transfection. Z-FLAG was detected by mouse anti-FLAG mAb followed by anti-mouse IgG-FITC antibody; GPC/ GP2 was detected by rabbit anti-GPC/GP2 polyclonal antibody followed by anti-rabbit IgG-Alexa Fluor 647 antibody. Lipid rafts were stained with a Vybrant Alexa Fluor 555 Lipid Raft labelling kit, and nuclei were stained with DAPI. The Z stack was also captured. In (c), the dotted square is shown at a higher magnification in the bottom right. The white arrows (c, d) indicate the co-localization of LASV Z and GPC/GP2. experiments using infectious LASV (Fehling et al., 2013) . Z alone (Fig 3(a) ) or Z+GPC (Fig 3(b) ) were expressed in 293T cells, and the intracellular localization of Z was examined by laser confocal microscopy, together with that of CD63. As shown in Fig. 3 , when Z was expressed alone, co-localization with CD63 was rarely detected. On the other hand, when GPC was co-expressed with Z, co-localization of CD63 and Z was observed approximately three times more frequently than with Z alone (Fig. 3c ).
VLP production induced by LASV Z and GPC requires Tsg101 and the viral L-domain
The data shown in Fig. 1 suggested that previously reported factors required for Z-mediated VLP production may be altered by the co-expression of GPC. Previously, we and other groups reported that LASV Z-mediated VLP budding requires Tsg101, which is one of the key components of the ESCRT machinery, as a host factor Urata et al., 2006) . Therefore, we examined whether Tsg101 also plays an essential role in LASV Z+GPC-mediated VLP production as a host factor (Garrus et al., 2001; Urata et al., 2006) . 293T cells were pre-treated with small interfering RNA (siRNA) specific for Tsg101 (siTsg101) or control siRNA (siCont), as described previously (Urata et al., 2006) , and then transfected with pCLV-Z and pCLV-GPC, together with siTsg101 or siCont. At 48 h post-transfection, the VLP fraction and cell lysate were collected. Viral and cellular proteins in each fraction or lysate were separated by SDS-PAGE and analysed by Western blotting using the indicated antibodies (Fig. 4a ). As shown in Fig.  4 (a), Z+GPC-mediated VLP production was decreased to 40 % of that of the control by depletion of Tsg101, suggesting that Tsg101 is involved in Z+GPC-mediated VLP budding as well as Z-mediated VLP budding Urata et al., 2006) .
We next examined whether L-domains still had an impact on LASV Z+GPC-mediated VLP production. We constructed expression plasmids for L-domain mutants of LASV Z, pCLV-Z-AAAP and pCLV-Z-PPPA, which have a PTAPAAAAP or PPPYAPPPA mutation, respectively. 293T cells were transfected with pCLV-Z, pCLV-Z-AAAP or pCLV-Z-PPPA, together with pCLV-GPC. At 48 h post-transfection, 
Involvement of Tsg101 and L-domains in Lassa VLP production. (a) 293T cells were transfected with scramble siRNA (siCont) or siRNA targeting Tsg101 (siTsg101). At 24 h posttransfection, the culture medium was replaced with fresh medium and the cells were transfected with each siRNA and both pCLV-Z and pCLV-GPC. VLP production was analysed as described in Fig. 1(a) . The efficiency of VLP production was calculated as described in Fig. 1(a) and the results are shown on the graph. (b) 293T cells were transfected with pCLV-Z (WT), pCLV-Z-AAAP (PTAPAAAAP mutation), or pCLV-Z-PPPA (PPPYAPPPA mutation), together with pCLV-GPC. VLP production was analysed as described in Fig. 1(a) . The efficiency of VLP production was also calculated as described in Fig. 1(a) . The data are means±SD from three independent experiments.
the VLP fraction and cell lysate were collected and analysed by Western blotting. As shown in Fig. 4(b) , intracellular expression levels of Z were similar among the WT and L-domain mutants. GP2 expression levels were also equivalent among cells expressing WT or mutant Z proteins. The levels of VLP production induced by both Z L-domain mutants were markedly decreased compared with that of WT (74 % reduction for pCLV-Z-AAAP and 85 % reduction for pCLV-Z-PPPA; Fig. 4b ).
Identification of the region within Z critical for VLP formation
We confirmed that L-domains within Z play a critical role in Z+GPC VLP production ( Fig. 4b) Strecker et al., 2003) . The whole RING domain in LASV Z has also been reported to be important for VLP production (Wang et al., 2012) . Nevertheless, functional domains other than G2, which is known to be important for Z myristoylation and subsequent virion production, the whole RING domain and L-domains have not been identified. To examine the existence of as-yet-unknown functional domains involved in Lassa VLP production, we constructed a series of LASV Z deletion mutants (Fig. 5a) , and performed VLP assay in 293T cells. As shown in Fig. 5(b) , the mutants showed various intracellular expression levels. However, VLP production efficiencies of most mutants were similar to that of the WT (Fig. 5c) . Only the D1 mutant with deletion of aa 3-10 showed a significant defect in VLP production. Although the reasons for the differences in intracellular Z expression levels of mutants are not clear, they may be related to the stabilities of the Z mutant proteins or the binding affinities of Z mutants to the anti-Z polyclonal antibody used in this study.
Previously, LASV GPC was reported to form a VLP without Z expression in several mammalian cell lines, including 293T cells (Schlie et al., 2010b) . Therefore, we examined whether co-expression of GPC rescued the VLP production defect of the D1 mutant in 293T cells. As shown in Fig. 5(d) , co-expression of GPC did not rescue this defect. G2 of LASV Z has been reported to be important for its myristoylation and the interaction with stable signal peptide in GPC (Capul et al., 2007) . As the D1 region is localized next to G2, we examined whether D1 affected the myristoylation of Z. 293T cells were transfected with empty vector, pCLV-Z, pCLV-ZD1 or pCLV-ZG2A, containing a GlyAAla mutation at aa 2, and myristoylation of each protein was examined as described in Methods. As shown in Fig. 5(e) , the expression levels of WT, D1 and G2A in cells were similar. WT was myristoylated, whilst D1 and G2A were not. Next, to examine whether this VLP production defect of D1 was due to deletion of this region, two mutants were constructed. Myristoylation of human immunodeficiency virus type 1 (HIV-1) Gag and Rous sarcoma virus (RSV) v-src at G2 have been documented previously (Freed et al., 1994; Kaplan et al., 1988; Ono & Freed, 1999) . Therefore, LASV Z amino aa 3-10 were replaced with HIV-1 Gag aa 3-10 or v-src aa 3-10 to construct pHIV-1 Gag10 LASV Z (HIV-1 Gag10) or pvsrc10 LASV Z (v-src10), respectively (Fig. 5f ). Both mutants showed reduced expression levels in the cells, and 48 and 42 % reductions in VLP production compared with WT based on normalized VLP production, respectively (Fig. 5g) . The intracellular localizations of these mutant proteins were also examined. As shown in Fig.  5(h) , these mutants were rarely co-localized with CD63 but were localized at the PM the same as the WT (Fig. 5h) .
Identification of the amino acid within positions 3-10 of Z critical for VLP production A defect in VLP production was observed in mutant D1, and replacement of LASV Z aa 3-10 with either HIV-1 Gag 3-10 or v-src 3-10 recovered this defect. To analyse further the importance of aa 3-10 of LASV Z, and to identify the amino acids critical for VLP production, three more mutants containing a linker sequence (GGGS) were constructed (Fig. 6a) . LASV Z aa 3-10 were replaced with GGGS62 to construct mut1 (Fig. 6a) . LASV Z aa 3-6 and 7-10 were replaced with GGGS to construct mut2 and mut3, respectively (Fig. 6a) . As mut1 showed a significant reduction of intracellular expression (Fig. 6b) , only mut2 and mut3 were used to examine VLP production. Both mut2 and mut3 showed lower protein expression levels compared with WT in the cells and reduction of the VLP production ratio compared with WT (65 and 54 % reduction, respectively) (Fig. 6c) . To examine the contribution of each amino acid to Z-mediated VLP production, single amino acid mutations were introduced into this region and a VLP assay was performed. As shown in Fig.  6(d) , none of these amino acid mutants showed a defect in Z-mediated VLP production. As reported previously, a G2A mutant showed complete abolition of VLP production due to the lack of myristoylation (Perez et al., 2004; Strecker et al., 2006) . Furthermore, we introduced double lysine to alanine mutation (K4,7A) to examine the contribution of double lysines, which may affect protein folding, on VLP production. Only modest reduction of VLP production was observed in the K4,7A mutant compared with that of the WT, suggesting that the single and double (K4,7) mutations examined in our assay were not critical for VLP production (Fig. 6e) .
DISCUSSION
Here, we showed that LASV GPC, but not NP, decreased Z-mediated VLP production in 293T cells (Fig. 1a) , and GPC also influenced the sensitivity of Z-mediated VLP production to MbCD treatment (Fig. 1b) . Interestingly, the sensitivity against MbCD treatment for VLP production was cell-type-dependent (Fig. 1b, c) . Huh-7 cells showed similar results to 293T cells (Fig. 1b, c) . Z+GPC-induced VLP production was reduced upon MbCD treatment, but Z-induced VLP production was unaffected (Fig. 1c , left 293T cells were transfected with pCLV-Z (WT) or the expression plasmid for each LASV Z deletion mutant. VLP production was analysed as described in Fig. 1(a) . (c) The efficiencies of VLP production of each Z mutant were calculated as described in Fig. 1(a) . The efficiency of the WT was set to 1.0. The data are means±SD from three independent experiments. (d) Effects of GPC expression on VLP production mediated by the D1 mutant. 293T cells were transfected with pCLV-Z or pCLV-ZD1 together with pCLV-GPC. VLP production was analysed as described in Fig. 1(a) . (e) Myristoylation of the D1 mutant. 293T cells were transfected with empty plasmid, pCLV-Z, pCLV-Z D1 or pCLV-ZG2A. At 18 h post-transfection, the culture medium was replaced with fresh medium containing ClickiT myristic acid azide (10 mM). At 6 h after medium exchange, cell lysates were prepared and used to perform a Click reaction panel). In Vero cells, both Z alone and Z+GPC-induced VLP production were reduced upon MbCD treatment (Fig. 1c, middle panel) . In MDCK cells, both Z alone and Z+GPC-induced VLP production were unaffected by MbCD treatment (Fig. 1c, right panel) . These results suggested that the cholesterol requirement for Z-or Z+GPC-mediated VLP production is cell-type-dependent. It was reported that both GP in LASV-infected MDCK cells and GP-transfected MDCK cells exhibited the same apical surface expression pattern, suggesting that the transient GP expression distribution showed the same pattern as LASV-infected GP (Schlie et al., 2010b) .
Previous studies on other arenaviruses, including Junin virus (JUNV), Mopeia virus, Pichinde virus and Tacaribe virus, as well as the present study, indicate that other viral with biotin alkyne according to the manufacturer's instructions. Purified proteins were detected with either rabbit anti-LASV Z polyclonal antibody followed by HRP-conjugated anti-rabbit IgG antibody or HRP-conjugated streptavidin. (f) Schematic representation of HIV-1 Gag10 and RSV v-src10. LASV Z amino acid sequence aa 3-10 was replaced with the aa 3-10 sequence of HIV-1 Gag or v-src. The asterisk (*) indicates the consensus myristoylation amino acid (Ser) at position 6. (g) 293T cells were transfected with pCLV-Z (WT) or pHIV-1 Gag10 LASV Z (HIV-1 Gag10) of pv-src10 LASV Z (v-src10). VLP production was analysed as described in Fig. 1(a) . ( The levels of VLP production of each single point mutant (d) or double lysine mutant (e) of LASV Z were analysed as described in Fig. 1(a) .
proteins could modulate Z-mediated VLP production and affect the efficiency of VLP production (Casabona et al., 2009; Groseth et al., 2010; Shtanko et al., 2010; Wang et al., 2012) . Therefore, we propose that co-expression of GPC together with Z is necessary to mimic LASV budding.
Based on the results shown in Fig. 1 indicating that cholesterol is required for Z+GPC-mediated VLP production in 293T cells, we examined whether lipid rafts, in which cholesterol is one of the main components, on the PM act as platforms for Z+GPC budding in 293T cells. Although co-localization of Z/GPC and lipid rafts was not detected, co-localization of Z and GPC/GP2 was sometimes detected (Fig. 2) . As cholesterol is involved in the virion membrane and plays a critical role in infection (Schlie et al., 2010a) , and the results presented here indicating that Z-or Z+GPC-mediated VLP production were reduced upn MbCD treatment but in a cell type-dependent manner, cholesterol appears to be an important trans factor for producing an infectious LASV. In addition, the observations that LASV Z and GPC are localized at detergent-soluble membrane regions in CHO-K1 cells (transfection system) and in Huh-7 cells (infection system) (Schlie et al., 2010a) and that LASV Z and GPC do not co-localize with lipid rafts (Fig. 2) indicate that these proteins are localized mainly at non-lipid rafts (detergentsoluble membrane areas). Considering these results, it is possible that once LASV Z and GPC reach the PM, they localize at non-lipid rafts but relocalize to the cholesterolrich domains (lipid rafts) just before budding and incorporate cholesterol into the virion, as proposed for JUNV (Agnihothram et al., 2009) .
It has been shown that LASV Z co-localizes with CD63 and M6PR, both of which are late endosomal markers (Fehling et al., 2013) . Therefore, we examined whether LASV Z alone or LASV Z+GPC co-localized with CD63. In fact, we found that GPC relocalized Z to CD63 (Fig. 3) , indicating that GPC is important to mimic Z-mediated VLP assembly and budding.
It was demonstrated that GPC expression did not alter the requirements for Tsg101 and L-domains in LASV Z and Z+GPC on VLP budding (Fig. 4a, b) . These results agreed with a previous report using the LASV infection system (Strecker et al., 2003) and suggested the involvement of LASV Z L-domains in virion production. These results (Figs 1 and 4) suggested that both Z and GPC are required to mimic LASV assembly/budding using the VLP system.
All arenavirus Z proteins reported to date have been shown to be matrix proteins with bona fide budding activity. To determine if there are other regions that regulate Zmediated VLP production than G2 or L-domains, which are well characterized, we constructed a series of deletion mutants and examined VLP production. We showed that the region consisting of aa 3-10 (D1) of LASV Z was critical for VLP production (Fig. 5a-c) , and this was due to the lack of myristoylation (Fig. 5e ). To examine whether LASV Z myristoylation and subsequent VLP production require specific amino acids within aa 3-10 of LASV Z, these residues of the original LASV Z sequence were replaced with HIV-1 Gag (HIV-1 Gag10) or RSV v-src (vsrc10). Both proteins are myristoylated at G2 (Fig. 5f ) (Freed et al., 1994; Ono & Freed, 1999; Schultz et al., 1985) . Both mutants showed lower protein expression levels compared with WT in the cells, suggesting that aa 3-10 are at least partially required for protein expression or stability. In addition, although the VLP production ratios were reduced compared with that of WT, both mutants rescued VLP production, suggesting that LASV Z does not require a specific amino acid in the region comprised of aa 3-10 for VLP production (Fig. 5g) . These mutants did not exhibit differences in intracellular distribution compared with WT (Fig. 5h) . Next, to explore further the importance of the aa 3-10 sequence for LASV Z-mediated VLP production, we generated a mutant (mut1) in which amino acids within the D1 (aa 3-10) region were replaced with the GGGS62 linker sequence (Fig. 6a, b ). We observed a significant reduction in expression of mut1 compared with the WT in cells. These observations, together with the results shown in Fig. 5(g ), supported the suggestion that the specific sequence of aa 3-10 in LASV Z is important for protein expression or stability. To narrow down the region important for LASV Z-mediated VLP production in LASV Z aa 3-10, two other mutants were constructed and VLP production was examined (Fig.  6c ). Both mutants exhibited less cellular expression and showed lower VLP production ratios than the WT. These results indicated that the sequences of aa 3-6 and 7-10 have some roles, but are not critical, for cellular expression or stability as well as VLP production. The reason for stable expression of the whole deletion of LASV Z aa 3-10 (D1) is not clear. Finally, to identify the specific amino acid that regulates VLP production with in the region of aa 3-10 in LASV Z, single amino acid mutations were introduced, and VLP assays were performed (Fig. 6d ). In addition, double lysine mutations (K4,7A) were also examined for VLP production efficiency (Fig. 6e) . None of the single or double mutation constructs showed reduction of VLP production, indicating that these single or double mutations were not sufficient for determining the amino acids responsible for VLP production in the D1 region. All arenavirus Z and several retroviral Gag proteins have been reported to be myristoylated at G2 for attachment to the cellular membrane (Bryant & Ratner, 1990; Göttlinger et al., 1989; Pal et al., 1990; Urata & Yasuda, 2012; Urata et al., 2009) , and this attachment is critical for the assembly and production of infectious progeny virions. To produce Lassa VLP, the aa 3-10 sequence does not have to be specific for LASV Z, as substitution of this region with HIV-1 Gag and RSV v-src recovered the defect of D1 VLP production, although the degree of recovery did not completely reach the WT level (Fig. 5g) . The ratios of VLP production induced by mut2 and mut3 were reduced compared with that of the WT. These results suggested that a specific amino acid within LASV Z aa 3-10 is required to produce VLP efficiently. Based on these results, we concluded that the whole region of aa 3-10 in LASV Z is critical for myristoylation and is important for efficient protein expression, stability and subsequent VLP production.
In conclusion, we have described several important aspects of the molecular mechanisms of LASV Z-and Z+GPC-mediated VLP production. As Z plays a central role in arenavirus assembly and budding, these findings will contribute to our understanding of LASV assembly and budding.
METHODS
Plasmids, siRNAs and antibodies. The expression plasmids for LASV Z (pCLV-Z) and GPC (pCLV-GPC) (both Josiah strain) were generated previously (Sakuma et al., 2009; Urata et al., 2006) . pCLV-Z-FLAG and pCLV-GPC-FLAG, which express Z and GPC with FLAG tags at their C termini, were also constructed by insertion of the FLAG-tag sequence into pCLV-Z and pCLV-GPC, respectively. The NP gene of Josiah strain was cloned into pcDNA3.1 (-) (Invitrogen) and the haemagglutinin (HA) tag was fused to its C terminus (pCLV-NP-HA). The expression plasmids for Z mutants were constructed with a QuikChange Site-Directed Mutagenesis kit (Stratagene) or KOD Plus Mutagenesis kit (Toyobo) according to the respective manufacturer's instructions. HIV-1 gag and RSV v-src genes were referenced from GenBank accession numbers AF324493.2 and K01644.1, respectively. The polyclonal antibodies against LASV Z or GPC/GP2 have been described previously (Sakuma et al., 2009; Urata et al., 2006) . Anti-HA (clone 6E2) and streptavidin-HRP were purchased from Cell Signaling Technology. Anti-FLAG M2 antibody to detect pCLV-GPC-FLAG on Western blotting was purchased from Sigma. Anti-CD63 antibody was obtained from Santa Cruz Biotechnology. The siRNA and antibody against Tsg101 have been described previously (Garrus et al., 2001; Urata et al., 2006) . Secondary antibodies against rabbit IgG and mouse IgG, both conjugated with HRP, were purchased from Promega and Sigma, respectively. The signals were detected using ECL Prime Western blotting Detection Reagents (GE Healthcare) according to the manufacturer's instructions.
Cells and MbCD treatment. 293T, Huh-7, MDCK and Vero cell lines were maintained with Dulbecco's modified Eagle's medium (DMEM) (Sigma) containing 10 % FBS and 1 % penicillin/streptomycin (Life Technologies). Cells were treated with MbCD (Sigma, 8.7 mM final concentration) for 30 min to chelate cellular cholesterol, and the culture medium was replaced with fresh medium before application of the transfection mixture.
VLP assay. Detection of LASV Z-mediated VLP production was as described previously (Urata et al., 2006) . Briefly, 293T cells were transfected with pCLV-Z (or mutants) and related plasmids with Trans-IT LT-1 (Mirus Bio). At 48 h post-transfection, cell debris was removed by centrifugation, and the medium was loaded on top of a 20 % sucrose cushion, followed by ultracentrifugation (195 000 g, 30 min, 4 uC) to collect VLPs. Cells were lysed with lysis A buffer [1 % Triton X-100, 25 mM Tris/HCl (pH 8.0), 50 mM NaCl, 10 % sodium deoxycholate], and cell debris was removed by centrifugation (13 000 g, 10 min, 4 uC). VLPs and cell lysate samples were separated by SDS-PAGE followed by Western blotting. Transfection of Huh-7, MDCK and Vero cells was performed with Lipofectamine 2000 (Invitrogen), and at 6 h post-transfection, the medium was replaced with fresh medium. Relative VLP production was calculated as total VLP-associated Z/cell-associated Z and normalized to the WT or control treatment as 1.0.
Immunofluorescence microscopy. At 24 h after transfection with pCLV-Z-FLAG and/or pCLV-GPC, 293T cells were fixed with 4 % paraformaldehyde (Wako) for 30 min at room temperature. Fixed cells were treated with blocking buffer [10 % FBS diluted with dilution buffer consisting of 3 % BSA+0.3 % Triton X-100 in PBS (-)(PBS lacking Mg 2+ and Ca 2+ )] for 1 h. After blocking, mAb against FLAG tag (clone M2; Sigma) and/or polyclonal antibody against LASV GPC/GP2, as well as Vybrant component A (Vybrant Alexa Fluor 555 Lipid Raft labelling kit; Life Technologies), were used to stain LASV Z, GPC/GP2 and lipid rafts (GM1), respectively. After 2 h of incubation at room temperature for the first staining, cells were washed twice with PBS (-), and goat anti-mouse IgG-FITC (Abcam) or goat anti-rabbit IgG-Alexa Fluor 647 (Abcam) was used to detect the primary antibodies for 2 h at room temperature. After the second staining, cells were washed twice with PBS (-), and DAPI was used to stain the nuclei for 30 min at room temperature. Finally, after three washes with PBS (-), cells were incubated with Vybrant component B for 15 min at 4 uC to cross-link the CT-B-labelled lipid rafts (Vybrant component A) with anti-CT-B antibody (Vybrant component B), and then washed three times with PBS(-), covered with glass coverslips and observed by confocal microscopy (LSM780; Zeiss). In the CD63 localization experiment, LASV Z and mutants were detected by anti-LASV Z polyclonal antibody, and CD63 was detected by anti-CD63 mAb. Goat anti-mouse IgG-FITC (Abcam) or goat anti-rabbit IgG-TRITC (Sigma) was used as the respective secondary antibody.
Detection of myristoylated protein. Click-iT myristic acid azide (Invitrogen), biotin alkyne (Invitrogen) and Click-iT protein reaction buffer kit (Invitrogen) were used to detect LASV Z myristoylation according to the manufacturer's instructions. Briefly, 293T cells (1610 6 ) were seeded and incubated for 6 h under 5 % CO 2 at 37 uC. After incubation, the cells were transfected with 0.5 mg plasmids using LT-1 and then cultured for a further 18 h. Culture medium was replaced with fresh medium containing Click-iT myristic acid azide at a final concentration of 10 mM. After 6 h of incubation, the cells were lysed with lysis buffer [50 mM Tris/HCl (pH 8.0), 1 % SDS] containing protease inhibitor (GE Healthcare) and benzonase (Sigma). After centrifugation (1300 g, 5 min, 4 uC) to remove cell debris, samples were used for a Click reaction using biotin alkyne, and methanol/ chloroform protein precipitation was performed to prepare the samples for SDS-PAGE. Samples of the same volume were loaded and detected by Western blotting with either rabbit anti-LASV Z polyclonal antibody followed by HRP-conjugated anti-rabbit IgG to detect LASV Z WT/ mutants or HRP-streptavidin to detect myristoylated proteins.
